AAAAAA
Results:
1-14
|
Results: 14
Authors:
BIBERGER C
VONANGERER E
Citation: C. Biberger et E. Vonangerer, 1-BENZYL-2-PHENYLINDOLE-BASED AND 1,2-DIPHENYLINDOLE-BASED ANTIESTROGENS - ESTIMATION OF AGONIST AND ANTAGONIST ACTIVITIES IN TRANSFECTION ASSAYS, Journal of steroid biochemistry and molecular biology, 64(5-6), 1998, pp. 277-285
Authors:
LEICHTL S
VONANGERER E
Citation: S. Leichtl et E. Vonangerer, 2-PHENYLBENZO[B]THIOPHENE-BASED ANTIESTROGENS WITH MAMMARY-TUMOR INHIBITING ACTIVITY, Archiv der pharmazie, 331(9), 1998, pp. 283-289
Authors:
GOLDBRUNNER M
LOIDL G
POLOSSEK T
MANNSCHRECK A
VONANGERER E
Citation: M. Goldbrunner et al., INHIBITION OF TUBULIN POLYMERIZATION BY 5,6-DIHYDROINDOLO[2,1-A]ISOQUINOLINE DERIVATIVES, Journal of medicinal chemistry, 40(22), 1997, pp. 3524-3533
Authors:
HAFNER F
HOLLER E
VONANGERER E
Citation: F. Hafner et al., EFFECT OF GROWTH-FACTORS ON ESTROGEN-RECEPTOR MEDIATED GENE-EXPRESSION, Journal of steroid biochemistry and molecular biology, 58(4), 1996, pp. 385-393
Authors:
BIBERGER C
VONANGERER E
Citation: C. Biberger et E. Vonangerer, 2-PHENYLINDOLES WITH SULFUR-CONTAINING SIDE-CHAINS - ESTROGEN-RECEPTOR AFFINITY, ANTIESTROGENIC POTENCY, AND ANTITUMOR-ACTIVITY, Journal of steroid biochemistry and molecular biology, 58(1), 1996, pp. 31-43
1-CARBAMOYLALKYL-2-PHENYLINDOLES - RELATIONSHIP BETWEEN SIDE-CHAIN STRUCTURE AND ESTROGEN ANTAGONISM
Authors:
VONANGERER E
BIBERGER C
HOLLER E
KOOP R
LEICHTL S
Citation: E. Vonangerer et al., 1-CARBAMOYLALKYL-2-PHENYLINDOLES - RELATIONSHIP BETWEEN SIDE-CHAIN STRUCTURE AND ESTROGEN ANTAGONISM, Journal of steroid biochemistry and molecular biology, 49(1), 1994, pp. 51-62
Authors:
MAHBOOBI S
GROTHUS G
VONANGERER E
Citation: S. Mahboobi et al., 3-SUBSTITUTED 2-PHENYLINDOLES - SYNTHESIS AND BIOLOGICAL PROPERTIES, Archiv der pharmazie, 327(8), 1994, pp. 481-492
Authors:
VONANGERER S
SEIDL E
MANNSCHRECK A
VONANGERER E
WIEGREBE W
Citation: S. Vonangerer et al., DIBENZO[A,F]QUINOLIZINES - SYNTHESES AND CYTOSTATIC ACTIVITY IN ESTROGEN-SENSITIVE TUMOR-CELLS, Anti-cancer drug design, 9(1), 1994, pp. 25-40
Authors:
VONANGERER E
KAGER M
MAUCHER A
Citation: E. Vonangerer et al., ANTITUMOR-ACTIVITY OF COUMARIN IN PROSTATE AND MAMMARY-CANCER MODELS, Journal of cancer research and clinical oncology, 120, 1994, pp. 14-16
Authors:
MAUCHER A
VONANGERER E
Citation: A. Maucher et E. Vonangerer, ANTITUMOR-ACTIVITY OF COUMARIN AND 7-HYDROXYCOUMARIN AGAINST 7,12-DIMETHYLBENZ[A]ANTHRACENE-INDUCED RAT MAMMARY CARCINOMAS, Journal of cancer research and clinical oncology, 120(8), 1994, pp. 502-504
Authors:
MEYER T
KOOP R
VONANGERER E
SCHONENBERGER H
HOLLER E
Citation: T. Meyer et al., A RAPID LUCIFERASE TRANSFECTION ASSAY FOR TRANSCRIPTION ACTIVATION EFFECTS AND STABILITY CONTROL OF ESTROGENIC DRUGS IN CELL-CULTURES, Journal of cancer research and clinical oncology, 120(6), 1994, pp. 359-364
Authors:
HORN DW
VOLLMER G
VONANGERER E
SCHNEIDER MR
Citation: Dw. Horn et al., EFFECT OF THE NONSTEROIDAL ANTIESTROGEN ZK-119.010 ON GROWTH AND METASTASIS OF THE ENDA ENDOMETRIAL CARCINOMA, International journal of cancer, 58(3), 1994, pp. 426-429
Authors:
VOLLMER G
SCHNEIDER MR
HORN D
VONANGERER E
KUPPEN R
Citation: G. Vollmer et al., ESTROGEN-RECEPTOR LEVELS IN ENDOMETRIAL A DENOCARCINOMA AND ADENOCARCINOMA CELL-LINES FOLLOWING ZK-119010 OR TAMOXIFEN TREATMENT, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 981-984
Authors:
MAUCHER A
VONANGERER E
Citation: A. Maucher et E. Vonangerer, ANTIPROLIFERATIVE ACTIVITY OF CASODEX (ICI-176.334) IN HORMONE-DEPENDENT TUMORS, Journal of cancer research and clinical oncology, 119(11), 1993, pp. 669-674
Risultati:
1-14
|